| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 85,000 | $2.18 | $185,138.50 | - | - | - | |
| Sep 15, 2023 | IRWD Ironwood Pharmaceuticals Inc | Emany Sravan Kumar47 | SVP, Chief Financial Officer | Buy | 36,072 | $8.32 | $300,119.04 | +23.6% | +37.3% | -45.2% | |
| Sep 14, 2023 | PBH Prestige Consumer Healthcare Inc. | Fritz Mary Beth57 | SVP Quality &Regulatory | Sell | 2,540 | $58.92 | $149,656.80 | -13.7% | +3.0% | +26.0% | |
| Sep 13, 2023 | VRNO Verano Holdings Corp. | Nunez Cristina Maria | Director | Sell | 3,491 | $4.62 | $16,128.42 | -9.4% | - | - | |
| Sep 13, 2023 | UTHR United Therapeutics Corp | Mesa Nilda47 | Director | Sell | 383 | $222.36 | $85,164.22 | -5.7% | +13.2% | +53.4% | |
| Sep 13, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 5,000 | $2.10 | $10,500.00 | - | - | - | |
| Sep 12, 2023 | JUSHF Jushi Holdings Inc. | Mosier Michelle O | Chief Financial Officer | Buy | 30,567 | $0.70 | $21,396.90 | +46.0% | - | - | |
| Sep 12, 2023 | NBIX Neurocrine Biosciences Inc | Lyons Gary A54 | Director | Sell | 5,000 | $115.02 | $575,120.00 | -2.4% | +1.2% | +3.7% | |
| Sep 12, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 15,000 | $2.11 | $31,603.50 | - | - | - | |
| Sep 12, 2023 | LLY Eli Lilly & Co | Weems Alonzo | EVP, Erm &Ceco | Sell | 1,148 | $590.98 | $678,445.04 | -12.9% | -2.5% | +53.7% | |
| Sep 12, 2023 | ASRT Assertio Holdings, Inc. | Peisert Daniel A.54 | President &CEO | Sell | 158,402 | $3.03 | $479,404.91 | -18.9% | -63.0% | -57.2% | |
| Sep 11, 2023 | ASRT Assertio Holdings, Inc. | Schlessinger Sam | SVP, General Counsel | Sell | 45,236 | $3.04 | $137,440.54 | -39.6% | -63.9% | -59.3% | |
| Sep 11, 2023 | TLPH Talphera, Inc. | Angotti Vincent J.56 | Chief Executive Officer | Buy | 10,000 | $0.80 | $7,950.00 | +12.2% | -5.6% | +18.5% | |
| Sep 11, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 100,000 | $2.22 | $221,600.00 | +0.1% | - | - | |
| Sep 11, 2023 | ASRT Assertio Holdings, Inc. | Schwichtenberg Paul | SVP And CFO | Sell | 104,980 | $3.07 | $322,593.04 | -62.0% | -63.9% | -59.3% | |
| Sep 11, 2023 | ASRT Assertio Holdings, Inc. | Patel Ajay | SVP And CAO | Sell | 64,313 | $3.04 | $195,794.50 | -40.7% | -63.9% | -59.3% | |
| Sep 8, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 25,000 | $2.19 | $54,867.50 | - | - | - | |
| Sep 8, 2023 | CBSTF Cannabist Co Holdings Inc. | Olson Bryan | Chief People/ Admin Officer | Sell | 70,385 | $1.22 | $86,151.24 | -19.0% | - | - | |
| Sep 7, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 210,000 | $571.41 | $119,995,274.66 | - | +2.8% | +57.5% | |
| Sep 7, 2023 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $222.98 | $1,337,904.69 | -5.0% | +7.8% | +55.2% | |
| Sep 7, 2023 | JUSHF Jushi Holdings Inc. | Mosier Michelle O | Chief Financial Officer | Buy | 66,500 | $0.75 | $49,875.00 | New | - | - | |
| Sep 6, 2023 | DERM Journey Medical Corp | Rosenwald Lindsay A Md64 | Director | Buy | 100,000 | $2.23 | $223,000.00 | +702.0% | +128.7% | +87.3% | |
| Sep 6, 2023 | CBSTF Cannabist Co Holdings Inc. | Olson Bryan | Chief People/ Admin Officer | Sell | 82,128 | $1.01 | $82,596.13 | -18.1% | - | - | |
| Sep 6, 2023 | EOLS Evolus, Inc. | Beaver Sandra67 | Chief Financial Officer | Sell | 3,178 | $9.70 | $30,826.60 | -2.7% | +1.7% | +53.5% | |
| Sep 6, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, EVP &Treasurer | Sell | 60,743 | $51.75 | $3,143,195.16 | -23.1% | +11.9% | -12.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.